Article ; Online: Heart and Lung Transplantation in the Era of COVID-19: Early Recommendations and Outcomes.
2021 Volume 19, Issue 11, Page(s) 1117–1123
Abstract: ... in the general population. Transplant organizations have disseminated early recommendations as a guidance in a yet evolving ... coronavirus and to prevent its transmission during nonurgent medical and surgical interventions. Heart and ... of time depending on the local virus epidemiology. The effect of this infection on the immunosuppressed heart and ...
| Abstract | The severe acute respiratory syndrome coronavirus 2 pandemic has dramatically changed medical practices worldwide. These changes have been aimed both to reallocate resources toward fighting the novel coronavirus and to prevent its transmission during nonurgent medical and surgical interventions. Heart and lung transplantation could not be an exception, as most transplant centers have either restricted their activity to only urgent, lifesaving procedures or stopped these surgical procedures for various periods of time depending on the local virus epidemiology. The effect of this infection on the immunosuppressed heart and lung transplant recipient is still questionable; however, there are limited reports suggesting that there is no increased risk of transmission or more severe disease course compared with that shown in the general population. Transplant organizations have disseminated early recommendations as a guidance in a yet evolving situation. Finally, data suggest that lung transplant could potentially serve as an ultimate, lifesaving procedure for COVID-19-related end-stage respiratory failure in carefully selected patients. |
|||||
|---|---|---|---|---|---|---|
| MeSH term(s) | COVID-19/immunology ; COVID-19/mortality ; COVID-19/surgery ; COVID-19/transmission ; Delivery of Health Care, Integrated ; Health Services Needs and Demand ; Heart Transplantation/adverse effects ; Heart Transplantation/mortality ; Humans ; Immunocompromised Host ; Immunosuppressive Agents/adverse effects ; Lung Transplantation/adverse effects ; Lung Transplantation/mortality ; Needs Assessment ; Patient Safety ; Risk Assessment ; Risk Factors ; Time Factors ; Treatment Outcome | |||||
| Chemical Substances | Immunosuppressive Agents | |||||
| Language | English | |||||
| Publishing date | 2021-02-01 | |||||
| Publishing country | Turkey | |||||
| Document type | Journal Article ; Review | |||||
| ZDB-ID | 2396778-X | |||||
| ISSN | 2146-8427 ; 1304-0855 | |||||
| ISSN (online) | 2146-8427 | |||||
| ISSN | 1304-0855 | |||||
| DOI | 10.6002/ect.2020.0289 | |||||
| Shelf mark |
|
|||||
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
| Zs.A 6632: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.